ANDROGEN RECEPTOR FUNCTION IN RECURRENT PROSTATE CANCER
ANDROGEN RECEPTOR FUNCTION IN RECURRENT PROSTATE CANCER
批准号:
6103478
负责人:
FRANK S FRENCH
金额:
$8.5万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 1999-07-31
关键词:
androgen receptor androgens athymic mouse biological signal transduction dehydroepiandrosterone dihydrotestosterone gel mobility shift assay gene expression genetic regulation genetic transcription growth factor hormone regulation /control mechanism hormone related neoplasm /cancer human tissue male mutant neoplasm /cancer genetics neoplasm /cancer relapse /recurrence neoplasm /cancer transplantation prostate neoplasms receptor expression tissue /cell culture xenotransplantation
中文摘要
人类前列腺是雄激素依赖性的,前列腺癌(CaP)
英文摘要
The human prostate is androgen dependent and prostate cancer (CaP)
maintains this dependence on androgens. It undergoes apoptosis and
regression following androgen withdrawal but eventually recurs in the
absence of testicular androgens. We are studying a human CaP xenograft
(CWR22) that retains these biological characteristics including regression
following androgen withdrawal and recurrence after several months in the
absence of androgen. Following the withdrawal of androgen stimulation,
androgen receptor (AR) levels decrease in CWR22. However, the recurrent
tumor CWR22R expresses a high level of AR relative to the androgen-
withdrawn CWR22. In the recurrent tumor AR exhibits intense nuclear
immunostaining suggests it is activated in the absence of androgen.
Moreover, androgen-regulated mRNAs that decreased following androgen
withdrawal are up-regulated in CWR22R in the absence of androgen
stimulation. The goal of the research will be to establish the role of AR
in mediating recurrent gene expression and cellular growth using the
CWR22/CWR22R model.
Specific Aims of this part of the proposal are to:
1. Identify mechanisms controlling the different steady state expression
levels of AR mRNA and protein in androgen withdrawn CWR22 and CWR22R.
2. Determine the activation state of AR in the recurrent tumor, CW22R, and
the role of growth factor signalling in AR activation.
3. Identify androgen-regulated genes in CW22 and determine their
expression levels in CWR22R.
A closely related Aim 4 will further characterize the mutant AR (H874Y)
which is expressed in CWR22 and has an altered steroid binding
specificity. Activation of the mutant AR by dihydrotestosterone is normal
in transcription assays but response to the adrenal-derived
dehydroepiandrosterone (DHEA) is greater than wild-type AR. We will
determine relative responsiveness of CWR22 and CWR22R to testicular
androgens and the ability of this mutant AR to mediate gene activation and
growth effects of DHEA. It is expected that this research will delineate
the role of AR and contribute to a better understanding of gene regulation
and growth in recurrent CaP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administration
-
批准号:8243676
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2011
-
负责人:FRANK S FRENCH
-
依托单位:
Administration
-
批准号:7963191
-
项目类别:
-
资助金额:$10.42万
-
财政年份:2010
-
负责人:FRANK S FRENCH
-
依托单位:
Molecular regulation in reproduction
-
批准号:7930141
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2009
-
负责人:FRANK S FRENCH
-
依托单位:
Administrative Core
-
批准号:7315900
-
项目类别:
-
资助金额:$17.35万
-
财政年份:2007
-
负责人:FRANK S FRENCH
-
依托单位:
CORE A
-
批准号:7141855
-
项目类别:
-
资助金额:$6.85万
-
财政年份:2005
-
负责人:FRANK S FRENCH
-
依托单位:
ANDROGEN RECEPTOR FUNCTION IN RECURRENT PROSTATE CANCER
-
批准号:6652760
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2002
-
负责人:FRANK S FRENCH
-
依托单位:
ANDROGEN RECEPTOR FUNCTION IN RECURRENT PROSTATE CANCER
-
批准号:6484138
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2001
-
负责人:FRANK S FRENCH
-
依托单位:
Epididymis-specific proteins for male contraception
-
批准号:6442075
-
项目类别:
-
资助金额:$3.9万
-
财政年份:2001
-
负责人:FRANK S FRENCH
-
依托单位:
Epididymis-specific proteins for male contraception
-
批准号:6622194
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2001
-
负责人:FRANK S FRENCH
-
依托单位:
Epididymis-specific proteins for male contraception
-
批准号:6691092
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2001
-
负责人:FRANK S FRENCH
-
依托单位:
ANDROGEN RECEPTOR FUNCTION IN RECURRENT PROSTATE CANCER
-
批准号:6344766
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2000
-
负责人:FRANK S FRENCH
-
依托单位:
ANDROGEN RECEPTOR FUNCTION IN RECURRENT PROSTATE CANCER
-
批准号:6203458
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1999
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen - Independence (CA77739)
-
批准号:7945768
-
项目类别:
-
资助金额:$151.45万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen - Independence (CA77739)
-
批准号:8470550
-
项目类别:
-
资助金额:$59.07万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen-Independence
-
批准号:6854921
-
项目类别:
-
资助金额:$126.18万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen - Independence (CA77739)
-
批准号:8650261
-
项目类别:
-
资助金额:$143.39万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen-Independence
-
批准号:7234309
-
项目类别:
-
资助金额:$129.71万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen - Independence (CA77739)
-
批准号:8117280
-
项目类别:
-
资助金额:$148.86万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen-Independence
-
批准号:7616862
-
项目类别:
-
资助金额:$133.63万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
Prostate Cancer: Transition to Androgen-Independence
-
批准号:7392846
-
项目类别:
-
资助金额:$130.14万
-
财政年份:1998
-
负责人:FRANK S FRENCH
-
依托单位:
海外基金